Trial NCT02826161

View at ClinicalTrials.gov 
Org. Study IDs: CanStem43L

Last trial update was posted on 2023-11-15

MeSH Interventions

Paclitaxel

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

Change of treatment landscape and evolving standard of care

Limitations And Caveats

On 12 June 2017 the sponsor notified study investigator that the study was terminated because of the rapidly evolving standard of care for patients with NSCLC. At the time of the termination, there were only 4 patients randomized (3 to the control arm and 1 to the napabucasin arm). Due to the small sample size, neither safety or efficacy data were analyzed or summarized for this study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID